USA 2024 Congress Sessions

Keynote Session 4 – Novel Lab Technologies

 

Keynote Session 4 – Novel lab technologies

 

Digital Transformation and Drug Discovery

Christopher Langmead, Executive Director and Head of Digital Biologics Discovery, Amgen

 

Empowering the Future of Collaborative, Digital Drug Discovery – From Small to Large Molecules

Erin Davis, SVP Enterprise Informatics, Schrodinger

 

LLMs and Liquid Handlers and GPTs, Oh My! Lab Automation in the Age of GenAI

Ramesh Durvasula, SVP R&D IT, Eli Lilly

 

Panel Discussion

Michael Shanler, VP Distinguished Analyst, Gartner

Christopher Langmead, Executive Director and Head of Digital Biologics Discovery, Amgen

Jessica Hilton, Former Head of Research Operations, Takeda

Erin Davis, SVP Enterprise Informatics, Schrodinger

Ramesh Durvasula, SVP R&D IT, Eli Lilly

Register for Premium Content

  • This field is for validation purposes and should be left unchanged.